Boosting the immunogenicity of the CoronaVac SARS-CoV-2 inactivated vaccine with Huoxiang Suling Shuanghua Decoction: a randomized, double-blind, placebo-controlled study
ConclusionOral HSSD boosts the immunogenicity of the CVS vaccine in young and adult individuals. This trial provides clinical reference for evaluation of TCM immunomodulators to improve the immune response to COVID-19 vaccines.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
More News: Allergy & Immunology | Biochemistry | China Health | Clinical Trials | Covid Vaccine | COVID-19 | Hormones | International Medicine & Public Health | Liver | Pandemics | SARS | Study | Urology & Nephrology | Vaccines | Vitamin B6 | Vitamins